LRFN1
Leucine-rich repeat and fibronectin type III domain-containing protein 1
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
protein domain | 0.97 | ||
tissue sample | 0.65 | ||
cell line | 0.56 | ||
gene perturbation | 0.53 | ||
tissue | 0.49 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Neuronal System | ||||
Reactome | Protein-protein interactions at synapses | ||||
Reactome | Synaptic adhesion-like molecules | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Neuronal System | ||||
Protein-protein interactions at synapses | ||||
Synaptic adhesion-like molecules | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Traceable Author Statement (TAS) | Reactome | |||
Inferred from Electronic Annotation (IEA) | UniProtKB-KW | |||
Inferred from Electronic Annotation (IEA) | Ensembl | |||
Inferred from Electronic Annotation (IEA) | Ensembl | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
7 | 3 | 0 | 2.2 | 91.3 | |||||
remission | 3 | 1 | 0 | 2.1 | 84.2 | ||||
3 | 1 | 0 | 2.1 | 84.2 | |||||
mitochondrial heteroplasmy measurement | 1 | 1 | 1 | 56.6 | |||||
viral load | 1 | 1 | 1 | 49.5 | |||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
0 | 2.2 | 91.3 | |||||
remission | 0 | 2.1 | 84.2 | ||||
0 | 2.1 | 84.2 | |||||
mitochondrial heteroplasmy measurement | 1 | 56.6 | |||||
viral load | 1 | 49.5 | |||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Chimp | leucine rich repeat and fibronectin type III domain containing 1 | VGNC:2416 | 456394 | |||||
Mouse | MGI:2136810 | 80749 | ||||||
Rat | RGD:1304707 | 365222 | ||||||
Dog | leucine rich repeat and fibronectin type III domain containing 1 | VGNC:42760 | 484512 | |||||
Horse | leucine rich repeat and fibronectin type III domain containing 1 | VGNC:19748 | 100067447 | |||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Chimp | leucine rich repeat and fibronectin type III domain containing 1 | |||||
Mouse | ||||||
Rat | ||||||
Dog | leucine rich repeat and fibronectin type III domain containing 1 | |||||
Horse | leucine rich repeat and fibronectin type III domain containing 1 | |||||
PMID | Year | Title |
---|